Search details
1.
Managing lines of therapy in castration-resistant prostate cancer: real-life snapshot from a multicenter cohort.
World J Urol
; 38(7): 1757-1764, 2020 Jul.
Article
in English
| MEDLINE | ID: mdl-31605196
2.
Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: an Italian multicenter "real life" study.
BMC Cancer
; 17(1): 753, 2017 Nov 10.
Article
in English
| MEDLINE | ID: mdl-29126389
3.
Duration of response to first androgen deprivation therapy, time to castration resistance prostate cancer, and outcome of metastatic castration resistance prostate cancer patients treated with abiraterone acetate.
Anticancer Drugs
; 28(1): 110-115, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27763885
4.
Systemic effect of radiotherapy before or after nivolumab in lung cancer: an observational, retrospective, multicenter study.
Tumori
; 108(3): 250-257, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-33818208
5.
The impact of locoregional treatments for metastatic castration resistant prostate cancer on disease progression: real life experience from a multicenter cohort.
Prostate Cancer Prostatic Dis
; 2022 Dec 02.
Article
in English
| MEDLINE | ID: mdl-36460734
6.
A 17-Gene Expression Signature for Early Identification of Poor Prognosis in Clear Cell Renal Cell Carcinoma.
Cancers (Basel)
; 14(1)2021 Dec 30.
Article
in English
| MEDLINE | ID: mdl-35008342
7.
Enzalutamide in patients with castration-resistant prostate cancer: retrospective, multicenter, real life study.
Minerva Urol Nephrol
; 73(4): 489-497, 2021 08.
Article
in English
| MEDLINE | ID: mdl-32748613
8.
Correlation of Tumor Location to Clinical Outcomes in Colorectal Cancer: A Single-institution Retrospective Analysis.
Anticancer Res
; 39(9): 4917-4924, 2019 Sep.
Article
in English
| MEDLINE | ID: mdl-31519596
9.
Castration-resistance prostate cancer: what is in the pipeline?
Minerva Urol Nefrol
; 70(1): 22-41, 2018 Feb.
Article
in English
| MEDLINE | ID: mdl-28707844
10.
Heterogeneity of PD-L1 Expression and Relationship with Biology of NSCLC.
Anticancer Res
; 38(7): 3789-3796, 2018 Jul.
Article
in English
| MEDLINE | ID: mdl-29970498
11.
Molecular Basis of Drug Resistance and Insights for New Treatment Approaches in mCRPC.
Anticancer Res
; 38(11): 6029-6039, 2018 Nov.
Article
in English
| MEDLINE | ID: mdl-30396917
12.
Abiraterone Acetate for Treatment of Metastatic Castration-resistant Prostate Cancer in Chemotherapy-naive Patients: An Italian Analysis of Patients' Satisfaction.
Clin Genitourin Cancer
; 15(5): 520-525, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28478884
13.
Clinical Outcome of Third-Line Pazopanib in a Patient with Metastatic Renal Cell Carcinoma.
Case Rep Oncol Med
; 2015: 629046, 2015.
Article
in English
| MEDLINE | ID: mdl-26798533
14.
Resistance to abiraterone in castration-resistant prostate cancer: a review of the literature.
Anticancer Res
; 34(11): 6265-9, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-25368223
15.
Genomic and epigenomic alterations in prostate cancer.
Front Endocrinol (Lausanne)
; 3: 128, 2012.
Article
in English
| MEDLINE | ID: mdl-23133437
Results
1 -
15
de 15
1
Next >
>>